{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:55:41Z","timestamp":1790070941380,"version":"4.0.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T00:00:00Z","timestamp":1531699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondation Bordeaux Universit\u00e9"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12890-018-0684-7","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T08:50:40Z","timestamp":1531731040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Comorbidities and COPD severity in a clinic-based cohort"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0015-2883","authenticated-orcid":false,"given":"Chantal","family":"Raherison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El-Hassane","family":"Ouaalaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bernady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Casteigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Nocent-Eijnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Falque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Le Guillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annaig","family":"Ozier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Molimard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,16]]},"reference":[{"issue":"4","key":"684_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMsa1211127","volume":"368","author":"MJ Thun","year":"2013","unstructured":"Thun MJ, et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med. 2013;368(4):351\u201364.","journal-title":"N Engl J Med"},{"key":"684_CR2","unstructured":"National Heart, L., and Blood Institute. World Health Organization., Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI\/WHO Workshop Report 2011. Vestbo J: National Institutes of Health; 2014. Available from: \n                    https:\/\/goldcopd.org\/gold-reports-2017\/\n                    \n                  ."},{"issue":"2","key":"684_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1164\/rccm.201201-0034OC","volume":"186","author":"M Divo","year":"2012","unstructured":"Divo M, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155\u201361.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"684_CR4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa021322","volume":"350","author":"BR Celli","year":"2004","unstructured":"Celli BR, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005\u201312.","journal-title":"N Engl J Med"},{"issue":"10","key":"684_CR5","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1164\/rccm.201207-1299OC","volume":"186","author":"P Lange","year":"2012","unstructured":"Lange P, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med. 2012;186(10):975\u201381.","journal-title":"Am J Respir Crit Care Med"},{"key":"684_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2147\/COPD.S76124","volume":"10","author":"UM Weinreich","year":"2015","unstructured":"Weinreich UM, et al. The effect of comorbidities on COPD assessment: a pilot study. Int J Chron Obstruct Pulmon Dis. 2015;10:429\u201338.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"8","key":"684_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","volume":"3","author":"W Chen","year":"2015","unstructured":"Chen W, et al. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631\u20139.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"684_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1513\/AnnalsATS.201403-125OC","volume":"12","author":"SI Rennard","year":"2015","unstructured":"Rennard SI, et al. Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. Ann Am Thorac Soc. 2015;12(3):303\u201312.","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"684_CR9","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1183\/09031936.00171614","volume":"46","author":"MJ Divo","year":"2015","unstructured":"Divo MJ, et al. COPD comorbidities network. Eur Respir J. 2015;46(3):640\u201350.","journal-title":"Eur Respir J"},{"issue":"7","key":"684_CR10","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1164\/rccm.201209-1665OC","volume":"187","author":"LE Vanfleteren","year":"2013","unstructured":"Vanfleteren LE, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728\u201335.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"684_CR11","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1183\/09031936.00009015","volume":"45","author":"BR Celli","year":"2015","unstructured":"Celli BR, et al. An official American Thoracic Society\/European Respiratory Society statement: research questions in COPD. Eur Respir J. 2015;45(4):879\u2013905.","journal-title":"Eur Respir J"},{"issue":"6","key":"684_CR12","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1183\/09031936.04.00014304","volume":"23","author":"BR Celli","year":"2004","unstructured":"Celli BR, MacNee W, Force AET. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper. Eur Respir J. 2004;23(6):932\u201346.","journal-title":"Eur Respir J"},{"issue":"8","key":"684_CR13","first-page":"1040","volume":"54","author":"PM Gold","year":"2009","unstructured":"Gold PM. The 2007 GOLD guidelines: a comprehensive care framework. Respir Care. 2009;54(8):1040\u20139.","journal-title":"Respir Care"},{"issue":"8","key":"684_CR14","first-page":"1219","volume":"12","author":"X Soler","year":"2015","unstructured":"Soler X, et al. High prevalence of obstructive sleep apnea in patients with moderate to severe chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2015;12(8):1219\u201325.","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"684_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1164\/rccm.200912-1869OC","volume":"182","author":"JM Marin","year":"2010","unstructured":"Marin JM, et al. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med. 2010;182(3):325\u201331.","journal-title":"Am J Respir Crit Care Med"},{"key":"684_CR16","doi-asserted-by":"crossref","unstructured":"Vanfleteren LE, et al. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir Med. 2016;4(11):911\u201324","DOI":"10.1016\/S2213-2600(16)00097-7"},{"issue":"19","key":"684_CR17","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMoa1505971","volume":"374","author":"PG Woodruff","year":"2016","unstructured":"Woodruff PG, et al. Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med. 2016;374(19):1811\u201321.","journal-title":"N Engl J Med"},{"key":"684_CR18","doi-asserted-by":"publisher","first-page":"420134","DOI":"10.1155\/2014\/420134","volume":"2014","author":"PR Burgel","year":"2014","unstructured":"Burgel PR, Paillasseur JL, Roche N. Identification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbidities. Biomed Res Int. 2014;2014:420134.","journal-title":"Biomed Res Int"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-018-0684-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-018-0684-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-018-0684-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T19:04:11Z","timestamp":1563217451000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-018-0684-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,16]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["684"],"URL":"https:\/\/doi.org\/10.1186\/s12890-018-0684-7","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,16]]},"assertion":[{"value":"7 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The CNIL (National Data Protection and Privacy Commission) and the CCTIRS (Advisory Committee for Data Processing in Health Research) approved the study, and informed verbal consent was obtained before enrollment. The authors had asked the local ethics committee for feedback regarding the need for ethical clearance for such a retrospective analysis, and were advised that this was not warranted.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Raherison reports grants from Bordeaux University Foundation, during the conduct of the study; personal fees from Astra Zeneca, personal fees from Chiesi, personal fees from ALK, personal fees from Boehringer Ingelheim, personal fees from Glaxo SmithKline, personal fees from MundiPharma, personal fees from Novartis, outside the submitted work; Dr. Nocent-Eijnani has nothing to disclose.Dr. Molimard reports personal fee from the University of Bordeaux, during the conduct of the study, other from Novartis Pharma, GSK, MundiPharma outside the submitted work. Dr. Nguyen has nothing to disclose. Dr. Falque has nothing to disclose. Dr. Casteigt has nothing to disclose. Dr. Le Guillou has nothing to disclose. Dr. Ozier has nothing to disclose. Dr. Bernady has nothing to disclose. Mr. Ouaalaya has nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"117"}}